Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
Clinical trial NCT05874310 · RECRUITING
Trial details
- NCT number
- NCT05874310
- Sponsor
- Frontera Therapeutics
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2023-10-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.